Dr. Joseph W. Bondranko Jr., MD

Dr. Bondranko practices at The University of Tennessee Medical Center in Knoxville, Tennessee, part of Ut Medical.

Dr. Bondranko's NPI, 1528036605, was assigned on March 14, 2006. Dr. Bondranko holds Tennessee license 23557.

Dr. Bondranko's primary practice is The University of Tennessee Medical Center, at 1924 Alcoa Highway, Knoxville, TN 37920 in Knox County. The practice phone is (865) 305-9000.

Dr. Bondranko's primary practice is The University of Tennessee Medical Center in Knoxville, Tennessee, part of Ut Medical. Dr. Bondranko is also affiliated with Methodist Medical Center of Oak Ridge. The medical group on file is University Anesthesiologists. Dmand AI also links Dr. Bondranko to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bondranko practices, 2 sites in all. Vendor and product names are available with a free account.

Anesthesiology is Dr. Bondranko's primary specialty in the NPI Registry, under taxonomy code 207L00000X. Dr. Bondranko is licensed in Tennessee.

CMS data shows 64 Medicare services from Dr. Bondranko across 3 procedure codes in 2024, for 205 Medicare patients. Medicare paid $3,259 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 205 Medicare patients who saw Dr. Bondranko in 2024. The largest group is 65 to 74, with 88 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.29, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bondranko's median patient age at 72, with 52% women.

Dr. Bondranko accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 14 general payments to Dr. Bondranko from 5 drug and device companies from 2017 to 2022. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $246.